Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing Point-of-Care Transfusion Requirements With Prolonged Desmopressin in High-Bleeding-Risk Cardiac Surgery: A Multicentre Randomized Controlled Trial (REDES-BLEED)

NCT07012837 is registered in ClinicalTrials.gov with Imam Abdulrahman Bin Faisal University as lead sponsor.

NCT NCT07012837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07012837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing Point-of-Care Transfusion Requirements With Prolonged Desmopressin in High-Bleeding-Risk Cardiac Surgery: A Multicentre Randomized Controlled Trial (REDES-BLEED)
Lead sponsor
Imam Abdulrahman Bin Faisal University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
July 31, 2025
Completion date
August 31, 2027
Enrollment
112 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult patients undergoing cardiac surgery, high bleeding risks, planned elective cardiac surgery using cpb